Quick Answer
Dare Bioscience, Inc. reported Common Stock Shares Outstanding of 14.50 million shares for the year ending 2025.
- Dare Bioscience, Inc. showed an increase of +66.7% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Dare Bioscience, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2013 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2013 to 2025), Dare Bioscience, Inc.'s Common Stock Shares Outstanding has grown by 1,745.8%.
- Historical annual values: Fiscal year 2025: 14.50 million shares | Fiscal year 2024: 8.70 million shares | Fiscal year 2024: 101.10 million shares | Fiscal year 2023: 8.33 million shares | Fiscal year 2022: 84.83 million shares | Fiscal year 2021: 83.94 million shares | Fiscal year 2020: 41.60 million shares | Fiscal year 2019: 19.68 million shares | Fiscal year 2018: 11.42 million shares | Fiscal year 2017: 6.05 million shares | Fiscal year 2016: 910,000 shares | Fiscal year 2015: 27.35 million shares | Fiscal year 2014: 20.13 million shares | Fiscal year 2013: 785,531 shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: